| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb8ea6cfe34a0afde7c67e3272e04ba8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| filingDate |
2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72f26785f3c7daf6e91597202cc342a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6249c88c9c624f9a004f2de18677ac96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2be60bc5ee12192d2ee4d110ab979008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b0579c183bb0048b40ccdf1c57f16d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c7156c3196cd45e7c495386fe57127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12eb9787914528edbfea15b092759f6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e34b6a2aacf7ec157741d78527c8922 |
| publicationDate |
2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2504377-C |
| titleOfInvention |
Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| abstract |
Disclosed is a lyophilized preparation of recombinant factor VIII used as a therapeutic preparation of hemophilia A. The lyophilized preparation of recombinant factor VIII is prepared by performing lyophilization using a mixture comprising 6 to 100 mM of L-arginine, 3.5 to 50 mM of L-isoleucine, and 10 to 100 mM of L-glutamic acid as a stabilizer for stabilizing the recombinant factor VIII which exhibits an unstable activity during lyophilization, rather than using human blood derived albumin. |
| priorityDate |
2004-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |